Cite
Homeobox D9 drives the malignant phenotypes and enhances the Programmed death ligand-1 expression in non-small cell lung cancer cells via binding to Angiopoietin-2 promoter.
MLA
He, Jiabei, et al. “Homeobox D9 Drives the Malignant Phenotypes and Enhances the Programmed Death Ligand-1 Expression in Non-Small Cell Lung Cancer Cells via Binding to Angiopoietin-2 Promoter.” World Journal of Surgical Oncology, vol. 21, no. 1, Mar. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12957-023-02969-z.
APA
He, J., Jiang, M., Liu, J., Zhu, R., Lv, W., Lian, R., Yang, Y., & Wang, R. (2023). Homeobox D9 drives the malignant phenotypes and enhances the Programmed death ligand-1 expression in non-small cell lung cancer cells via binding to Angiopoietin-2 promoter. World Journal of Surgical Oncology, 21(1), 1–13. https://doi.org/10.1186/s12957-023-02969-z
Chicago
He, Jiabei, Mengjia Jiang, Jing Liu, Ruiping Zhu, Weipeng Lv, Ruiqing Lian, Yang Yang, and Ruoyu Wang. 2023. “Homeobox D9 Drives the Malignant Phenotypes and Enhances the Programmed Death Ligand-1 Expression in Non-Small Cell Lung Cancer Cells via Binding to Angiopoietin-2 Promoter.” World Journal of Surgical Oncology 21 (1): 1–13. doi:10.1186/s12957-023-02969-z.